SME Times is powered by   
Search News
Just in:   • Equity indices break two-day losing streak on value buying  • IMF urges Sri Lanka to tighten monetary policy  • Global semiconductor sales to reach $676 bn this year: Gartner  • Tinna Rubber hits upper circuit, investors accumulate 900% returns in year  • Availability of jobs in Japan improves for 1st time in 3 yrs 
Last updated: 27 Sep, 2014  

Biosafe Affirms its Leadership in India

PR Newswire | 23 Sep, 2013
EYSINS, Switzerland: Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively.

In the public stem cell banking area, Jeevan Blood Bank and Research Centre in Chennai is expanding its program and will process its full volume of stem cell samples with Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device.

On the family banking side, the renowned companies Cordlife India and Cryobanks International are likewise moving to automated processing exclusively by Sepax.

Such expansion is a milestone as the majority of cord blood samples in India will now be processed with Biosafe technology.

Olivier Waridel, CEO of the Biosafe Group, commented: "These recent wins illustrate the potential of Biosafe's Sepax technology in the BRIC economies. Biosafe demonstrates its ability to meet customer expectations through its vast portfolio of processing solutions and is committed to further support stem cell banking expansion in India together with Span Healthcare".

About the Biosafe Group

Founded in 1997 the Biosafe Group is active in the design, manufacture and marketing of automated cell processing systems. Headquartered in Switzerland and privately-owned, the Biosafe Group operates through regional subsidiaries (Geneva, Houston, Hong-Kong, Shanghai and São Paulo) and is present in more than 45 countries, either directly or through distributors.

For further information:

Christopher Bolton
CFO
Biosafe Group
+41-22-365-27-27
christopher.bolton@biosafe.ch
http://www.biosafe.ch

SOURCE Biosafe Group

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 27 Apr, 2022
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter